-+ 0.00%
-+ 0.00%
-+ 0.00%

CERVOMED’S NEFLAMAPIMOD ELECTED FOR INCLUSION IN UK EXPERTS-ALS PLATFORM DESIGNED TO PRIORITIZE PROMISING TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS

Reuters·02/18/2026 11:01:48

Please log in to view news